Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.105 -0.075 (-1.21%)
Streaming Delayed Price Updated: 3:48 PM EDT, Jun 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers. 
Via Benzinga
The Smart Money Is Buying These 10 Stocks
Via Benzinga
Earnings Scheduled For April 30, 2025
Via Benzinga
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Via ACCESS Newswire
Earnings Scheduled For February 19, 2025
Via Benzinga
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings. 
Via Benzinga
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Via ACCESS Newswire
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Via ACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
Via ACCESS Newswire
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Via ACCESS Newswire
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
Via ACCESS Newswire
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares
This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers. 
Via Stocktwits
Bausch Health Announces Filing of Supplement to Proxy Statement
Via ACCESS Newswire
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Via ACCESS Newswire
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
Via ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
Via ACCESS Newswire
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
Via ACCESS Newswire
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises
The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China. 
Via Stocktwits
Topics Earnings
Exposures Financial
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance
Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report: 
Via Benzinga
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.